Transcept Pharmaceuticals Inc 4
4 · Transcept Pharmaceuticals Inc · Filed Dec 17, 2013
Insider Transaction Report
Form 4
LOAR MATTHEW M
Director
Transactions
- Award
Common Stock (right to buy)
2013-12-16+25,000→ 25,000 totalExercise: $3.30Exp: 2023-12-16→ Common Stock (25,000 underlying)
Holdings
- 54,755
Common Stock
Footnotes (1)
- [F1]The option vests in thirty-six equal monthly installments beginning on January 16, 2014.